Important Updates in AI and Healthcare Coverage for 2024

Discover the groundbreaking shifts shaping the future of healthcare in 2024. Explore how AI tools are revolutionizing Medicare Advantage Insurance Plans, enhancing diagnostic accuracy, and predictive modeling. Delve into the journey from concerns raised in 2023 to the implementation of new federal regulations in 2024, ensuring AI algorithms align with Medicare coverage criteria. Witness the emphasis on individual circumstances and human oversight in healthcare coverage decisions, empowering every insurance member with the right to appeal denial decisions. Welcome to the era where technology meets compassion in shaping personalized healthcare solutions.

Prior Authorization Staffing: The need for certified experts

In a healthcare landscape burdened by delays and financial strains, the Prior Authorization Certified Specialist (PACS) Program emerges as a beacon of hope, offering accredited, self-paced training to bridge the knowledge gap, streamline processes, and significantly improve outcomes for both providers and patients.

340B Drug Pricing & Prior Authorizations

A growing number of complex, expensive medications are entering the market. At the same time, health insurance companies, also called payer, are increasingly relying on utilization management to control healthcare costs by influencing patient care decisions. Common utilization management tools include prior authorizations, step therapy, predeterminations, and preauthorizations.

Utilization Management: Here’s What You Need to Know

A growing number of complex, expensive medications are entering the market. At the same time, health insurance companies, also called payer, are increasingly relying on utilization management to control healthcare costs by influencing patient care decisions. Common utilization management tools include prior authorizations, step therapy, predeterminations, and preauthorizations.

5 Tips to Become a Field Reimbursement Manager

Field reimbursement managers (FRMs) are the backbone of a life science organization. FRMs support commercial (i.e., sales teams) with the patient reimbursement journey, ensuring patients receive therapy in a timely and cost-effective manner and assisting life science organizations with their primary objective of improving patient lives.

The Impact of Prior Authorization on Patient Compliance and Adherence

As medications become more intricate and expensive, medication access barriers prevent patients from acquiring their prescriptions and continuing medication regimens. The prior authorization (PA or prior auth) process is one of the access obstacles patients face when trying to acquire their medications.

Electronic Prior Authorization Reform: What’s Next?

The legislation will streamline the prior authorization process for the more than 28 million Medicare Advantage members. Medicare Advantage (MA) plans, sometimes called “Part C” or “MA Plans,” are Medicare-approved plans from private companies offering an alternative to original Medicare for health and medication coverage.

4 Tips for Prior Authorization Success

Prior authorizations (prior auths or PAs) are a cost management tool utilized by insurance companies. PAs increase administrative costs for HCPs and create a healthcare obstacle for patients. HCPs depend on prior authorization approvals and insurance payments to remain in business. Healthcare providers (HCPs) must master a productive prior authorization workflow to improve productivity and revenue.

An Essential Guide to Step Therapy

Health insurance companies increasingly employ cost management strategies as more expensive, specialized drugs enter the market. The use of step therapy is one of these cost-control strategies. The goal of step therapy is for patients to try low-cost medications before moving on to more costly ones.

Will Prescriber “Gold Cards” Solve the Prior Authorization Problem?

Imagine a world with fewer prior authorizations. A new Texas law aims to make this dream a reality. House Bill 3459(HB 3459), or the “Gold Card Act,” grants prescribers a “continuous prior authorization exemption” if they have a 90% approval rating on previous authorization requests.